
Jushi Holdings Inc.
Jushi Holdings Inc. (JUSH.CN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
jush.cn · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Jushi Holdings Inc.You JUSH.CN | $146M | N/A | — | -$0.36 |
Cardiol Therapeutics Inc. CRDL.TO | $169M | N/A | — | -$0.39 |
Grown Rogue International Inc. GRIN.CN | $165M | 16.92x | +13.6% | $0.03 |
Helix BioPharma Corp. HBP.TO | $117M | N/A | — | -$0.09 |
HLS Therapeutics Inc. HLS.TO | $138M | N/A | — | -$0.40 |
Cannara Biotech Inc. LOVE.V | $181M | 12.86x | -13.6% | $0.14 |
MariMed Inc. MRMD.CN | $40M | N/A | — | -$0.04 |
Industry Average 2 peers with valid PE | — | 14.89x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Jushi Holdings Inc. (JUSH.CN) measures how much investors pay for each dollar of the company's trailing earnings. JUSH.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.73 by its TTM earnings per share of -$0.36.
Frequently asked questions
JUSH.CN pe ratio · 6 questionsJUSH.CN's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.73 and TTM EPS of -$0.36. Data sourced from Financial Modeling Prep via JUSH.CN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Jushi Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09